Literature DB >> 24725697

Changes in functional lung regions during the course of radiation therapy and their potential impact on lung dosimetry for non-small cell lung cancer.

Xue Meng1, Kirk Frey2, Martha Matuszak3, Stanton Paul3, Randall Ten Haken3, Jinming Yu4, Feng-Ming Spring Kong5.   

Abstract

PURPOSE: To study changes in functional activity on ventilation (V)/perfusion (Q) single-photon emission computed tomography (SPECT) during radiation therapy (RT) and explore the impact of such changes on lung dosimetry in patients with non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: Fifteen NSCLC patients with centrally located tumors were enrolled. All patients were treated with definitive RT dose of ≥60 Gy. V/Q SPECT-CT scans were performed prior to and after delivery of 45 Gy of fractionated RT. SPECT images were used to define temporarily dysfunctional regions of lung caused by tumor or other potentially reversible conditions as B3. The functional lung (FL) was defined on SPECT by 2 separate approaches: FL1, a threshold of 30% of the maximum uptake of the patient's lung; and FL2, FL1 plus B3 region. The impact of changes in FL between initiation of RT and delivery of 45 Gy on lung dosimetry were analyzed.
RESULTS: Fourteen patients (93%) had larger FL2 volumes than FL1 pre-RT (P<.001). Dysfunctional lung became functional in 11 patients (73%) on V SPECT and in 10 patients (67%) on Q SPECT. The dosimetric parameters generated from CT-based anatomical lung had significantly lower values in FL1 than FL2, with a median reduction in the volume of lung receiving a dose of at least 20 Gy (V20) of 3%, 5.6%, and mean lung dose of 0.95 and 1.55 on V and Q SPECT respectively.
CONCLUSIONS: Regional ventilation and perfusion function improve significantly during RT in centrally located NSCLC. Lung dosimetry values vary notably between different definitions of functional lung.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24725697      PMCID: PMC4400732          DOI: 10.1016/j.ijrobp.2014.01.044

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

1.  The incorporation of SPECT functional lung imaging into inverse radiotherapy planning for non-small cell lung cancer.

Authors:  Judith A Christian; Mike Partridge; Elena Nioutsikou; Gary Cook; Helen A McNair; Bernadette Cronin; Frederic Courbon; James L Bedford; Michael Brada
Journal:  Radiother Oncol       Date:  2005-11-07       Impact factor: 6.280

2.  High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study.

Authors:  Feng-Ming Kong; Randall K Ten Haken; Matthew J Schipper; Molly A Sullivan; Ming Chen; Carlos Lopez; Gregory P Kalemkerian; James A Hayman
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-01       Impact factor: 7.038

3.  Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy.

Authors:  L Christine Fang; Ritsuko Komaki; Pamela Allen; Thomas Guerrero; Radhe Mohan; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-09-01       Impact factor: 7.038

4.  A methodology for using SPECT to reduce intensity-modulated radiation therapy (IMRT) dose to functioning lung.

Authors:  Sarah M McGuire; Sumin Zhou; Lawrence B Marks; Mark Dewhirst; Fang-Fang Yin; Shiva K Das
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-01       Impact factor: 7.038

5.  The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram.

Authors:  L B Marks; D P Spencer; G W Sherouse; G Bentel; R Clough; K Vann; R Jaszczak; R E Coleman; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-08-30       Impact factor: 7.038

6.  Reverse ventilation-perfusion mismatch in lung cancer suggests intrapulmonary functional shunting.

Authors:  M Wartski; E Zerbib; J F Regnard; P Hervé
Journal:  J Nucl Med       Date:  1998-11       Impact factor: 10.057

7.  A potential to reduce pulmonary toxicity: the use of perfusion SPECT with IMRT for functional lung avoidance in radiotherapy of non-small cell lung cancer.

Authors:  Konstantin Lavrenkov; Judith A Christian; Mike Partridge; Elena Niotsikou; Gary Cook; Michelle Parker; James L Bedford; Michael Brada
Journal:  Radiother Oncol       Date:  2007-05-09       Impact factor: 6.280

Review 8.  The role of radiotherapy in lung cancer: where is the evidence?

Authors:  Jacek Jassem
Journal:  Radiother Oncol       Date:  2007-05-04       Impact factor: 6.280

9.  Using fluorodeoxyglucose positron emission tomography to assess tumor volume during radiotherapy for non-small-cell lung cancer and its potential impact on adaptive dose escalation and normal tissue sparing.

Authors:  Mary Feng; Feng-Ming Kong; Milton Gross; Shaneli Fernando; James A Hayman; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-03-15       Impact factor: 7.038

10.  Effective avoidance of a functional spect-perfused lung using intensity modulated radiotherapy (IMRT) for non-small cell lung cancer (NSCLC): an update of a planning study.

Authors:  Konstantin Lavrenkov; Shalini Singh; Judith A Christian; Mike Partridge; Elena Nioutsikou; Gary Cook; James L Bedford; Michael Brada
Journal:  Radiother Oncol       Date:  2008-11-06       Impact factor: 6.280

View more
  14 in total

1.  Rebuttal from Prof. Kong and Dr. Rabatic.

Authors:  Bryan M Rabatic; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2016-04

2.  Image-based lung functional radiotherapy planning for non-small cell lung cancer.

Authors:  Faegheh S Mounessi; Jörg Eckardt; Arne Holstein; Santiago Ewig; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2019-10-02       Impact factor: 3.621

3.  Measuring interfraction and intrafraction lung function changes during radiation therapy using four-dimensional cone beam CT ventilation imaging.

Authors:  John Kipritidis; Geoffrey Hugo; Elisabeth Weiss; Jeffrey Williamson; Paul J Keall
Journal:  Med Phys       Date:  2015-03       Impact factor: 4.071

4.  Lung and Heart Dose Variability During Radiation Therapy of Non-Small Cell Lung Cancer.

Authors:  Nuzhat Jan; Christopher Guy; Leonid B Reshko; Geoffrey D Hugo; Elisabeth Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-03-08       Impact factor: 7.038

Review 5.  Nondosimetric risk factors for radiation-induced lung toxicity.

Authors:  Feng-Ming Spring Kong; Shulian Wang
Journal:  Semin Radiat Oncol       Date:  2014-12-15       Impact factor: 5.934

Review 6.  Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization.

Authors:  Michael MacManus; Sarah Everitt; Tanja Schimek-Jasch; X Allen Li; Ursula Nestle; Feng-Ming Spring Kong
Journal:  Transl Lung Cancer Res       Date:  2017-12

7.  Virtual Bronchoscopy-Guided Treatment Planning to Map and Mitigate Radiation-Induced Airway Injury in Lung SAbR.

Authors:  Narges Kazemzadeh; Arezoo Modiri; Santanu Samanta; Yulong Yan; Ross Bland; Timothy Rozario; Henky Wibowo; Puneeth Iyengar; Chul Ahn; Robert Timmerman; Amit Sawant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-02       Impact factor: 7.038

8.  Changes in Regional Ventilation During Treatment and Dosimetric Advantages of CT Ventilation Image Guided Radiation Therapy for Locally Advanced Lung Cancer.

Authors:  Tokihiro Yamamoto; Sven Kabus; Matthieu Bal; Karl Bzdusek; Paul J Keall; Cari Wright; Stanley H Benedict; Megan E Daly
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-05-04       Impact factor: 7.038

9.  Modeling Patient-Specific Dose-Function Response for Enhanced Characterization of Personalized Functional Damage.

Authors:  Daniel Rocky Owen; Phillip S Boonstra; Benjamin L Viglianti; James M Balter; Matthew J Schipper; William C Jackson; Issam El Naqa; Shruti Jolly; Randall K Ten Haken; Feng-Ming Spring Kong; Martha M Matuszak
Journal:  Int J Radiat Oncol Biol Phys       Date:  2018-06-01       Impact factor: 7.038

10.  Stereotactic body radiotherapy for Stage I lung cancer with chronic obstructive pulmonary disease: special reference to survival and radiation-induced pneumonitis.

Authors:  Toshihiko Inoue; Hiroya Shiomi; Ryoong-Jin Oh
Journal:  J Radiat Res       Date:  2015-04-16       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.